← All trials
NCT07309432
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 19, 2026
- Primary completion
- Feb 28, 2027
- Completion date
- Jun 15, 2027
- First posted
- Dec 30, 2025
- Last posted
- Dec 30, 2025
- Enrollment
- 350
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.